Target Markets With a direct-to-consumer UK model and strong international distribution, Cambridge Nutraceuticals should pursue partnerships and wholesale arrangements in markets with established nutraceutical distributors, focusing on Australia as a key growth region and expanding to similar high-demand regions.

Clinical Credibility Leverage the robust clinical foundation and university-level testing to position products as evidence-backed solutions for cardiovascular and joint health, targeting healthcare professionals, clinics, and wellness programs that value validated benefits.

Expanded Product Line Capitalize on 41 published studies for TURMERIC+ and ongoing trials by proposing bundled bundles or cross-sell opportunities across product lines, appealing to customers seeking comprehensive, multi-ingredient supplements with proven efficacy.

Strategic Partnerships Engage with research institutions, NHS trusts, and academic collaborators to co-create and co-market advanced formulations, increasing credibility, trial sponsorships, and access to institutional buyers.

Funding Leverage The existing funding runway and modest revenue suggest opportunities for strategic investors or licensing deals to accelerate scale, distribution expansion, and production capacity to meet growing demand.